Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: Results of a prospectively randomised Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)

We conducted a prospectively randomised clinical trial to investigate the role of adjuvant outpatient immunochemotherapy administered postoperatively in high-risk patients with renal cell carcinoma. In total, 203 renal carcinoma patients' status post radical tumour nephrectomy were stratified i...

Descripción completa

Detalles Bibliográficos
Autores principales: Atzpodien, J, Schmitt, E, Gertenbach, U, Fornara, P, Heynemann, H, Maskow, A, Ecke, M, Wöltjen, H H, Jentsch, H, Wieland, W, Wandert, T, Reitz, M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361915/
https://www.ncbi.nlm.nih.gov/pubmed/15756254
http://dx.doi.org/10.1038/sj.bjc.6602443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361915/
https://www.ncbi.nlm.nih.gov/pubmed/15756254
http://dx.doi.org/10.1038/sj.bjc.6602443

Ejemplares similares